With the new year right around the corner, Lilly Library wants to remind the public of its offerings and weekly events that ...

Eli Lilly and Company (NYSE: LLY) is one of the best forever stocks to buy according to hedge funds. On December 15, Goldman ...

Lily Allen is opening up about one of the most personal decisions she made after her split with David Harbour: her boob job. The singer has been in the spotlight again thanks to her new album and ...

When it comes to depicting raw, emotional honesty about the societal expectations placed on trans women, Geena Rocero is not ...

In this video, Halle C. F. Moore, MD, discusses the EMBER-3 study update evaluating imlunestrant for women with hormone receptor-positive, HER2-negative breast cancer, presented at San Antonio Breast ...

For Jacob Van Naarden, Executive Vice President and President of Lilly Oncology, the mission is clear: bring better cancer ...

Alicia Yoon went from battling eczema with $7 in her bank account to bringing glass skin into the American skincare ...

Eli Lilly and Co shared updated results of Inluriyo (imlunestrant) from a Phase 3 study in previously treated breast cancer patients.

Eli Lilly will not seek a broad FDA approval for a combination of the company’s oral SERD med Inluriyo and CDK4/6 inhibitor ...

Sacituzumab govitecan failed to extend PFS in patients with hormone receptor-positive, HER2-negative breast cancer following ...

Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eli Lilly achieved a $1 trillion market cap, a healthcare first, ...